Skip to main content

Featured

Ukraine Sends Specialist Teams to Counter Drone Threats

A Ukrainian military instructor demonstrates the operation of an interceptor drone designed to destroy Russian attack drones in the Kyiv region of Ukraine, March 11, 2026. Ukraine has deployed military and engineering units to five Middle Eastern countries —the United Arab Emirates, Saudi Arabia, Qatar, Kuwait, and Jordan —to help intercept drones and strengthen air‑defense capabilities amid escalating regional tensions.  The teams, composed of specialist counter‑drone personnel , are advising local forces and assisting in neutralizing Iranian-made Shahed drones , which have increasingly targeted civilian and critical infrastructure during the ongoing Iran conflict. Ukrainian officials say the mission aims to bolster regional security and pave the way for long‑term defense cooperation agreements .  President Volodymyr Zelensky and Ukrainian security council secretary Rustem Umerov emphasized that while Middle Eastern partners focus on ballistic missile threats, Ukrainian un...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment